Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT01194258
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 132 participants
- Sponsor
- Halozyme Therapeutics
- Registry
-
NCT01194258
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01194258. Randomized; quadruple masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-08 (actual). Results posted on 2014-08-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type II
- Intervention (Drug)
- Insulin lispro
- Intervention (Drug)
- Insulin aspart
- Intervention (Drug)
- Recombinant human hyaluronidase PH20
- Intervention (Drug)
- Insulin glulisine
- Intervention (Drug)
- Insulin glargine
- Lead sponsor
- Halozyme Therapeutics
Record details
- Record id
cardio:ct-nct01194258- Content hash
af7c2e184f1447daf230844fd78c69e9594ccca3df05db72dc315443049cef72